How Economics Drives Excellence in Cardiothoracic Care?
In today’s healthcare landscape, hospitals are under increasing pressure to deliver better outcomes while managing costs. Thopaz+ offers a transformative solution in chest drainage management1. A solution that not only improves clinical results but also significantly reduces the total cost of care.
Clinical Excellence Meets Economic Efficiency
Thopaz+ is a digital chest drainage system designed to optimize postoperative care in cardiothoracic adults and paediatric patients. Its clinical benefits are well-documented when compared to analogue systems:
Quantified Cost Savings: The YHEC Cost Model Results 4
The York Health Economics Consortium (YHEC) developed a robust cost model comparing Thopaz+ to conventional analogue systems across 2,500 patients. The findings are compelling:
• Average savings of £1,152 per patient4
• Length of stay reduced by 1.3 days on average4
• Staff monitoring time cut by 68%4
• X-rays reduced by 57%, drain reinsertions by 80%4
• Higher surgical throughput: more procedures per bed per year4
These savings are rooted in robust, real-world evidence. They reflect tangible improvements that hospitals are already experiencing in practice, validated through peer-reviewed publications, clinical trials, and independent evaluations by the National Institute for Health and Care Excellence (NICE)3.
Strategic Value for Hospitals
Thopaz+ is more than a device. It is a strategic investment. Hospitals that adopt Thopaz+ are not just purchasing equipment; they are unlocking a system that:
• Improves patient outcomes 1,2,3
• Reduces complications and re-explorations 1
• Optimizes resource utilization 5,6,7
• Increases operational efficiency 5,6,7
• Generates long-term financial savings 3,4,8
Regardless if you purchase, rent the device or pay per use, Thopaz+ delivers a net positive return4. The system pays for itself (and more) through reduced bed occupancy, lower complication rates, and streamlined care delivery.
Value-Based Healthcare in Action
Thopaz+ enables hospitals to deliver higher-quality care at lower cost, aligning clinical excellence with financial sustainability. By investing in Thopaz+, whether in cardiac, thoracic, paediatric settings or whenever a chest drain is required, hospitals are not only improving patient outcomes but also reducing the overall cost of care, saving far more than they spent on the system. 1,3,4,8
Contact us to find out more
